Ganoderma lucidum polysaccharide peptide (GLPP) scavenges oxygen free radicals that are a key factor in the pathogenesis of renal ischemia reperfusion injury (RIRI). The aim of this study was to determine whether GLPP could attenuate RIRI by counteracting the oxidative stress. The mechanism involved was assessed by an in vivo mouse RIRI model and an in vitro hypoxia/reoxygenation model, and tunicamycin-stimulated NRK-52E cells were used to explore the GLPP-mediated alleviation of ER stress. Experimental results showed that renal dysfunction and morphological damage were reduced in GLPP-treated group. The imbalance of redox status was reversed and production of ROS was reduced by GLPP. RIRI-induced mitochondrial- and ER stress-dependent apoptosis were dramatically inhibited in GLPP-treated group. Intriguingly, JNK activation in the kidney with RIRI or hypoxia/reoxygenation was inhibited by GLPP. These results suggest that the protective effect of GLPP against RIRI may be due to reducing oxidative stress, alleviating the mitochondrial and ER stress-dependent apoptosis caused by excessive ROS.
Ganoderma lucidum has been widely used as a traditional medicine in Asian countries to treat diseases, such as tumors1,2,3, liver disorders4, hypercholesterolemia5, obesity6 and cerebral ischemia reperfusion (IR)7. Ganoderma lucidum polysaccharide peptide (GLPP) was isolated from boiling water extract of the fruiting body of Ganoderma lucidum (Leyss ex Fr) Karst (Gl), followed by ethanol precipitation, dialysis and protein depletion using the Sevag method. This polysaccharides peptide has a molecular weight of approximately 5 × 105 with a polysaccharide to peptide ratio of approximately 95%/5%. The polysaccharides consist of D-rhamnose, D-xylose, D-fructose, D-galactose and D-glucose with molar ratios of 0.549:3.614:3.167:0.556:6.89 and linked together by β-glycosidic linkages8. GLPP is the major pharmacological constituent of Ganoderma lucidum and has diverse bioactivities9,10,11, among which, its antioxidant and radical-scavenging features suggest that GLPP may play a role in the pathophysiological mechanisms of renal ischemia reperfusion injury (RIRI).
RIRI inevitably occurs during surgery to treat occlusion of the renal arteries or the aorta and is a leading cause of perioperative acute kidney injury (AKI). AKI, characterized by an abrupt decrease in the glomerular filtration rate, is a common surgical complication that leads to unacceptably high mortality, chronic kidney disease (CKD) and end-stage renal disease12. RIRI involves a complex and interrelated sequence of events that result in the injury of renal cells and eventual cell death due to apoptosis and necrosis13. Although reperfusion is essential for the survival of ischemic tissue, reperfusion itself causes additional cell injury, which has been attributed to calcium overload, neutrophil infiltration and the generation of ROS14. Clinical and experimental studies have discovered that ROS play a vital role in tissue damage and cell apoptosis during IR, particularly during the process of reperfusion. ROS cause lipid peroxidation of biological membranes, disrupting structural integrity and energy production, especially in the proximal tubule segment highly susceptible to acute ischemia and hypoxia15,16.
During the process of RIRI, the mitochondria are the major sources and targets of ROS. Oxidative stress interferes with not only redox-dependent reactions but also with protein folding, ultimately resulting in protein misfolding in the endoplasmic reticulum (ER)17. Altered redox homeostasis in the ER is sufficient to cause ER stress, which in turn induces the production of ROS, both in the ER and in the mitochondria. Several studies have proven that ER stress and mitochondrial dysfunction are intimately linked to the pathogenesis of RIRI18. GLPP is able to reduce the accumulation of ROS that are closely associated with the pathophysiology of kidney failure and renal diseases11. Therefore, we proposed that GLPP may prevent and alleviate RIRI by restoring the balance of the oxidation/antioxidant system. In the current study, mouse RIRI model and a series of molecular pharmacology methods were used to investigate whether GLPP exerts a protective role against RIRI and its possible mechanisms involved were studied. The experimental results showed that GLPP could prevent RIRI, indicating that GLPP may be developed as a candidate drug for preventing RIRI.
GLPP protected the kidney against RIRI
Renal function was assessed by the levels of blood urea nitrogen (BUN) and blood creatinine. Both parameters were significantly increased after renal IR compared with sham-operated mice. However, the administration of GLPP before ischemia and reperfusion resulted in improved renal function, as demonstrated by decreased BUN and creatinine levels (Fig. 1A,B).
Hematoxylin and eosin (H & E) staining was performed for the morphological analysis of renal tissues. Compared with sham-operated mice, proximal tubular damage including tubular brush border loss and dilatation and outer medulla injury including intertubular haemorrhage and congestion were found in the IR group. However, no significant damage was seen in inner medulla, which confirmed that the IR-induced renal injury was predominantly in proximal tubulars16. These changes were attenuated by GLPP pretreatment (Fig. 1C,D). Results above suggest that GLPP pretreatment exerts significant protective effect against RIRI.
We further explored whether postoperative administration of GLPP protected against RIRI. GLPP was intraperitoneally administered at the beginning of reperfusion. After 24 hours, blood and kidney samples were collected for analysis. GLPP did not significantly lower the IR-increased levels of BUN and blood creatinine (Fig. 1E,F). Additionally, post-treatment with GLPP did not observably reduce morphological changes caused by renal IR (Fig. 1G,H).
GLPP modified renal oxidative stress and lipid peroxidation after IR
Oxidative stress plays a key role in the activation of mitochondrial and ER stress, which results in a series of abnormalities such as apoptosis, necrosis and other serious consequences. Myeloperoxidase (MPO), malondialdehyde (MDA), superoxide dismutase (SOD), catalase (CAT), reduced glutathione (GSH) and glutathione peroxidase (GSH-Px) were detected for evaluating the effect of GLPP on IR-mediated oxidative stress in the kidney. Compared with the sham group, RIRI significantly increased the levels of MPO and MDA and decreased the activities of SOD, CAT, GSH and GSH-Px while GLPP reversed these changes caused by IR (Fig. 2A–F). We then detected the expression of manganese superoxide dismutase (Mn-SOD), which is an important cellular antioxidant enzyme. As shown in Fig. 2G, IR significantly decreased the expression of Mn-SOD while GLPP increased its expression. Additionally, we isolated cell membrane and cytosol proteins separately for evaluating the changes of p47phox, a core regulatory subunit of NADPH oxidase, to promote NADPH oxidase-dependent production of ROS. It was found that IR stimulated the expression and translocation of p47phox to the membrane while GLPP inhibited its translocation, suggesting that the beneficial effect of GLPP may be partially attributed to alleviating the NADPH oxidase-dependent production of ROS.
GLPP inhibited IR-induced apoptosis by reducing mitochondrial and ER stress
Impaired redox status results in accumulation of ROS, thus activates mitochondrial and ER stress. When homeostasis is disrupted and adaptive responses fail to compensate for the stress, apoptosis is triggered. A TUNEL assay was used to evaluate apoptosis in renal tissues induced by IR. More apoptotic cells appeared in kidneys subjected to IR than in the sham-operated kidneys. GLPP reduced IR-induced TUNEL-positive cells by 21.75%, which suggests that GLPP protects kidneys from renal tubular apoptosis (Fig. 3A). Results were confirmed by Western blot analysis, demonstrated as decreased ratios of p-p53/p53 and cleaved caspase-3/caspase-3 in the IR GLPP-treated group (Fig. 3B).
We then analyzed the ratio of Bax/Bcl-2 that reflects mitochondrial-related apoptosis. GLPP reduced the ratio of Bax/Bcl-2 caused by IR, which demonstrated that GLPP restored mitochondrial function. Correspondingly, we isolated mitochondrial fractions from IR kidneys and detected the expression of cytochrome c in both the mitochondrial and cytosolic fractions. The results showed that IR caused more cytochrome c release from mitochondria to the cytosol while GLPP reduced the ratio of Bax/Bcl-2 and inhibited the release of cytochrome c (Fig. 4A). These results indicate that GLPP inhibits the mitochondria-dependent apoptosis induced by IR.
The expression of 78 kDa glucose-regulated protein (GRP78), CCAAT/enhancer-binding protein (C/EBP)-homologous protein (CHOP) and caspase-12 was increased after IR, which suggested that the kidneys had undergone serious ER stress. Additionally, the phosphorylation of JNK increased in the IR group, which played a pivotal role in ER stress-induced apoptosis. GLPP reduced the expression of these ER stress biomarkers and inhibited the activation of JNK (Fig. 4B), indicating that GLPP inhibits IR-induced apoptosis, presumably by alleviating ER stress.
GLPP increased cell viability and reduced cell oxidative stress induced by hypoxia/reoxygenation (H/R)
A CCK-8 assay was used to assess the cytotoxicity of GLPP. At concentrations from 1.1 μg/ml to 810 μg/ml, GLPP showed no obvious cytotoxicity on NRK-52E cells (Fig. 5A). Hypoxia for 12 h followed by reoxygenation for 1 h significantly decreased the cell viability compared to control cells. Pretreatment with GLPP improved cell viability in a dose-dependent manner (Fig. 5B).
We then studied the effect of GLPP against cellular oxidative stress. The H/R significantly reduced the activities of SOD and GSH, which was associated with a reciprocal increase in MDA level and ROS production (Fig. 5C,D). The translocation of p47phox to membrane was inhibited and the expression of Mn-SOD was increased by GLPP in a dose dependent manner (Fig. 5E), indicating that GLPP has a protective role against H/R by inhibiting the activation of NADPH oxidase and increasing antioxidant activity, which finally reduces the accumulation of ROS and alleviates the oxidative stress.
GLPP inhibited cell apoptosis induced by H/R
NRK-52E cell apoptosis was analyzed by TUNEL assays and Western blot assays. More apoptotic cells appeared in the H/R group compared with the control group while GLPP significantly reduced H/R-increased apoptotic cells (Fig. 5F), which was in accordance with the in vivo results. The protein levels of p-p53, p53, cleaved caspase-3 and caspase-3 were further tested (Fig. 5H). In line with the mouse model, we found that H/R increased cell apoptosis by means of up-regulating of the ratios of p-p53/p53 and cleaving capsase-3/caspase-3. However, pretreatment with GLPP reversed these ratios in a dose-dependent manner, which confirmed the results of the TUNEL analysis. All these data suggest that GLPP has a protective effect against H/R-induced apoptosis in renal tubular cells.
GLPP attenuated H/R-induced mitochondrial dysfunction
To determine whether H/R affected mitochondrial function, NRK-52E cells were analyzed by fluorescent, lipophilic and JC-1 (cationic probe) staining. We found that H/R resulted in significant dissipation of mitochondrial ΔΨm, indicated by increased green fluorescence. GLPP-pretreated cells exhibited attenuated ΔΨm dissipation caused by H/R (Fig. 6A), which indicates that GLPP pretreatment diminishes H/R-induced mitochondrial dysfunction. Increased Bax expression and decreased Bcl-2 expression were found in the H/R group while GLPP reversed these expression changes. Furthermore, H/R resulted in cytochrome c releasing from the mitochondria into the cytosol, which was suppressed by GLPP in a dose-dependent manner (Fig. 6B).
GLPP reduced ER stress-dependent apoptosis
To explore the influence of GLPP on H/R-induced ER stress, we then tested the changes in GRP78, caspase-12 and CHOP. H/R increased the expression of these proteins, whereas GLPP dramatically reversed these changes (Fig. 7A). Afterwards, tunicamycin (TM), an ER stress inducer, was used to stimulate NRK-52E cells and to create a special ER stress model. We found that TM significantly increased the expression of GRP78, caspase-12 and CHOP, suggesting that NRK-52E cells underwent serious ER stress. Interestingly, both H/R and TM increased the phosphorylation of JNK, while 4-PBA, a specific inhibitor of ER stress, or GLPP significantly inhibited the expression of p-JNK and ER stress markers (Fig. 7B), demonstrating that GLPP relieves ER stress-induced apoptosis at least partially through the JNK signaling pathway (Fig. 7B).
The aim of this study was to determine whether GLPP could protect kidneys against RIRI and to elucidate the related mechanisms. RIRI is a common cause of AKI in patients during renal transplantation or with recanalization after occlusion of renal blood flow. Mice RIRI model is generally used to study the mechanisms in which AKI occurs and to evaluate potential anti-AKI activity of active compounds. In the current study, GLPP restored the balance of oxidative stress induced by IR, indicating a protective effect of GLPP against IR, likely related to improvement in the endogenous antioxidant system.
MDA is an index of oxidative stress and also a prominent product of lipid peroxidation19. SOD is an indicator of anti-oxidative capacity, involved in reversing the pathological changes in oxidative injury. It is well accepted that SOD, CAT, GSH and GSH-Px play important roles in the endogenous defense system against oxygen free radicals20,21. Generally, increased MDA and decreased SOD, CAT, GSH, GSH-Px in kidney tissue after IR has been documented22,23. In the current study, administering GLPP before IR or treatment with GLPP before H/R decreased renal MDA and increased endogenous antioxidant enzymes. We also found that the increased ROS production and decreased Mn-SOD expression caused by IR or H/R were reversed by GLPP. Interestingly, it was found that the IR or H/R induced activation of NADPH oxidase was significantly inhibited by GLPP. All these results indicate that GLPP may reduce the NADPH oxidase-dependent production of ROS and increase ROS elimination to normalize the imbalance between the anti-oxidative and oxidative status after IR.
Accumulated ROS may activate mitochondrial stress pathways to cause mitochondrial injury. Mitochondria are the main sources of ROS in the process of reperfusion, and contribute critically to the pathogenesis of IR by activating the signaling pathways of cell injury and apoptosis. High ROS activity indicates depolarization of the mitochondrial membrane, which increases the expression of the pro-apoptotic protein Bax on the outer mitochondrial membrane24. Bax is a membrane protein of the Bcl-2 family that participates in regulating mitochondrial membrane permeabilization and the mitochondrial-dependent pathway of apoptosis25,26. In renal cells, IR or H/R increases the expression of Bax and decreases the expression of Bcl-2. Altered ratio of Bax/Bcl-2 promotes the release of cytochrome c. Accumulated cytochrome c in the cytosol activates caspase-9, which is responsible for the apoptotic initiation process27. The activated caspase-9 then proteolytically cleaves and activates executioners such as caspase-3, which eventually trigger cell apoptosis28. In our study, H/R resulted in significant dissipation of mitochondrial ΔΨm and increased ratios of Bax/Bcl-2 and cleaved caspase-3/caspase-3. In addition, more cytochrome c was released from the mitochondria to the cytosol, which indicated that the cells had undergone apoptosis via a mitochondria-dependent pathway.
Previous studies have proven that the G. lucidum peptides play substantial protective roles in rat liver tissue homogenates and mitochondrial membrane peroxidation systems through their antioxidant, metal-chelating and free radical-scavenging activities29. GLPP may also protect the mitochondria from tert-butylhydroperoxide (t-BOOH)-caused injury due to its antioxidative capacity11. Our data showed that GLPP treatment restored the balance of oxidative stress, ameliorated mitochondrial function and reduced cell apoptosis in IR. Basing on these findings, we propose that GLPP alleviates oxidative stress by reducing ROS production and accumulation, thus reducing mitochondrial stress-dependent apoptosis.
ER stress is one of the various mechanisms contributing to cellular damage and apoptosis30,31. Previous studies strongly suggest that ER stress plays a key role in the pathogenesis of several renal cell injury and kidney diseases, including renal tubular epithelial cell apoptosis32, podocyte injury in diabetic nephropathy33 and IR-induced AKI34. Excessive ER stress triggered by ischemia or H/R usually results in the up-regulation of the ER stress response protein GRP7835. GRP78 is an ER chaperone, a key unfolded protein response (UPR) with multiple roles in protein processing and cellular protection and is a marker of ER stress36. CHOP is considered as an ER stress-associated pro-apoptotic protein and the target of UPR signaling pathways and pro-apoptosis during the ER stress response in AKI37,38.
Caspase-12, expressed ubiquitously and constitutively, is exclusively located in the ER39. Unlike other caspases, caspase-12 is specifically activated by insult-induced ER stress-dependent apoptosis40,41. Caspase-12 and p-JNK were up-regulated in the IR-exposed kidney18 and over-expressed in the diabetic kidney42. Activated JNK translocates to mitochondrial membrane, where it is decisive for cytochrome c release. Studies have shown that JNK is involved in ER stress-induced apoptosis in lung epithelial cells43 and HeLa cells44. Additionally, the concomitant occurrence of both ER stress markers and JNK activation indicate that JNK activation occurs downstream of ER stress45 and that the ER stress-JNK pathway plays an important role in mediating insulin resistance and apoptosis46,47.
In our study, the Western blot analysis revealed that the expression of GRP78, CHOP and caspase-12 elevated notably after IR and H/R, indicating that ER stress participated in IR or H/R induced apoptosis. However, GLPP pretreatment reduced these parameters. To further confirm that GLPP protects against AKI by ameliorating ER stress, we built an ER stress model in vitro by incubating NRK-52E cells with TM for 24 h. Intriguingly, GLPP alleviated TM-induced ER stress in a dose-dependent manner, which firstly proved that GLPP could directly inhibited the ER stress. The activation of JNK was involved in TM-induced ER stress, while 4-PBA or GLPP inhibited its activation, suggesting that the JNK signaling pathway is involved in ER stress-induced apoptosis and the renal-protective effect of GLPP may be attributed to the alleviation of ER stress-dependent apoptosis.
Based on our experimental data, we suggest a mechanism in which GLPP protects the kidneys from RIRI (Fig. 8). RIRI results in the generation and accumulation of ROS in renal tissue, which surpasses the scavenging capacity of endogenous antioxidases. The excessive ROS activate both mitochondrial stress and ER stress pathways. When the mitochondria are impaired, the increased Bax and decreased Bcl-2 alters the ratio of Bax to Bcl-2 in the outer membrane of mitochondria and promotes the release of cytochrome c. Released cytochrome c activates the apoptotic effector protein, caspase-3, which eventually induces mitochondrial-dependent cell apoptosis. At the same time, accumulated ROS also activate ER stress, showing as the increased expression of GRP78, activated caspase-12 and CHOP, which ultimately triggers the onset of ER stress-dependent apoptosis. ER stress may also activate the JNK signaling pathway, which could enhance the release of cytochrome c and further contribute to cell apoptosis.
Ganoderma lucidum has been reported to have wide effects in suppressing inflammation48 and increases the activity of SOD in cerebral IR7. MPO is a characteristic constituent of neutrophil granules and represents ROS-related inflammation. In our study, GLPP treatment reduced IR-induced MPO activity in kidney, suggesting that a potentially harmful effect of MPO in immune-mediated inflammation might be alleviated by GLPP. It has been reported that immune response and inflammation in RIRI49,50,51 and GLPP exerts beneficial effect on injury of macrophages by inhibiting the foam cell formation and necrosis21. The effect of GLPP on immune response and inflammation in RIRI and related mechanism need to be further explored.
Previous studies have showed effects of Ganoderma lucidum and its extracts on renal injury. The hot water extract of Ganoderma lucidum dose-dependently reduced mouse kidney lipid peroxidation induced by 95% ethanol52. Other studies indicated that Ganoderma extract significantly reduced oxidative damage and apoptosis in human proximal tubular epithelial cells induced by human serum albumin53, while Lingzhiols, extracted from Ganoderma lucidum, could inhibit TGF-β/Smads signaling pathways54. Moreover, a novel proteoglycan from Ganoderma lucidum fruiting bodies conferred significant amelioration on renal function and morphologic injuries in diabetic nephropathy mice55. These studies suggest that Ganoderma lucidum and its extracts have wide renal protective activities and a good application prospect in different kidney diseases.
In summary, the current study verifies, for the first time, that GLPP has beneficial effects on IR caused AKI. The protective effect of GLPP against RIRI may be attributed to the inhibition of NADPH oxidase-dependent production of ROS and the increase of free radical-scavenging capacity for the balance of the oxidation/antioxidant system, improving mitochondrial dysfunction and ER stress-dependent apoptosis, which subsequently alleviates AKI caused by IR. Our study suggests that GLPP may be developed as a candidate drug for preventing AKI.
Materials and Methods
GLPP is a hazel-colored, water-soluble powder, kindly provided by Fuzhou Institute of Green Valley Bio-Pharm Technology. The compound’s average molecular weight is approximately 520 kDa, as determined by high-performance steric exclusion chromatography analysis. In the experiments, GLPP was dissolved in physiological saline for animal treatment and in PBS for cell incubation.
All procedures in this study were carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of China Association for Laboratory Animal Science. All animal care protocols were approved by the Animal Care Committee of Peking University Health Science Center. All sacrifices were performed under pentobarbitone anesthesia and every effort was made to minimize animal suffering.
Acute renal injury mouse model
Male C57BL/6J mice (8 weeks-10 weeks old) weighing 20 g–22 g were purchased from the Animal Center of Peking University Health Science Center. The animals were housed with a 12 h/12 h light/dark cycle and food and water were available ad libitum. The mice were divided randomly into four groups: the sham-operated group; the sham-operated GLPP-treated group; the IR group; and the IR GLPP-treated group. For the warm renal IR, the mice were anesthetized by intraperitoneal injections of sodium pentobarbital (80 mg/kg). Then, the right renal pedicle was identified and occluded with a small vascular clamp for 35 min while the left kidney was removed. For reperfusion, the clamp was released and the kidney was monitored by a change in the color of the kidney to confirm blood reflow before suturing the incision. Sham-operated animals underwent an identical operation without renal pedicle clamping. In order to analyze the prevention efficacy of GLPP against IR injury, 100 mg/kg/day of GLPP was intraperitoneally injected for 7 days before the procedure until sacrifice. For evaluating the therapeutic effect of GLPP on RIRI, GLPP was given by intraperitoneal injection at the onset of reperfusion. After reperfusion for 24 h, blood and kidney samples were collected for further study.
Blood BUN and creatinine measurement
After reperfusion for 24 h, blood samples were collected to determine the levels of blood BUN and creatinine. BUN was measured using a quantitative colorimetric urea determination kit (QuantiChrom Urea Assay Kit-DIUR-500). Blood creatinine concentrations were measured with commercial kits (NJJC Bio, Nanjing, China), according to the manufacturer’s instructions.
H & E staining
Kidneys were fixed with 4% formaldehyde for subsequent paraffin embedding and sectioning. The sections were stained with H & E for morphological analysis. Tissue damage was assessed using a tubular damage score, as previously described56. Briefly, injury was scored in a blinded manner according to the percentage of damage included loss of brush border, tubular dilation and intertubular haemorrhage: 0, no damage; 1, < 25%; 2, 25 ~ 50%; 3, 50 ~ 75%; 4, > 75%. Representative fields were captured.
Measurement of biomarkers of oxidative stress
Homogenized renal samples were tested for MPO, MDA, SOD, CAT, GSH and GSH-Px activities using specific assay kits (NJJC Bio, Nanjing, China) according to the manufacturer’s instructions.
The NRK-52E cells (rat renal proximal tubule epithelial cells) were purchased from the Cell Resource Center of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (Shanghai, China). Briefly, the NRK-52E cells were cultured in DMEM containing 10% fetal bovine serum (FBS; Gibco), 2 mM glutamine, 100 U/ml penicillin and 100 μg/ml streptomycin, in a humidified atmosphere with 5% CO2 at 37 °C
The NRK-52E cell H/R model was designed to mimic renal cell I/R injury in vitro. Before the procedure, the NRK-52E cells were cultured to 70% to 80% confluence and then they were serum deprived for 24 h. GLPP, at a concentration of 1 μg/ml, 5 μg/ml or 25 μg/ml, was added to the cell cultures 12 h before hypoxia. In all the H/R processes, the cells were incubated in starving low-glucose DMEM under low-oxygen (1% O2) for 12 h in a humidified hypoxia incubator (Thermo Fisher Scientific, USA). The cells were then exposed to normal oxygen (95% air + 5% CO2) for 1 h. After the completion of the procedure, the supernatant and cells were collected separately for further analysis. Control groups were cultured in normal conditions, coincident with the duration of H/R injury and the supernatant and cells were harvested separately for further analysis.
Cytotoxicity and viability assay
The CCK-8 assay kit (Dojindo) was used for testing cytotoxicity in vitro. NRK-52E cells were planted in 96-well plates at a density of 5000 cells/well. GLPP was co-incubated with NRK-52E cells for 24 h. Then, the CCK-8 solution, at a 1/10 dilution with 10% FBS DMEM, was added to each well and the cells were incubated for 3 h at 37 °C. Absorbance at 450 nm was measured with a microplate reader (Biotek, MQX200). To analyze the effect of GLPP on cell viability in NRK-52E affected by H/R, the cells were pretreated with GLPP for 12 h and the H/R protocol was performed. Cell viability was calculated as follows:
Detection of intracellular ROS production and biomarkers of oxidative stress
Cells planted in 96-well plates were subjected to H/R protocol. After reoxygenation, cells were washed twice with PBS and incubated in the presence of 10 μM 2′-7′-Dichlorodihydroflurescein diacetate (DCFH-DA, Sigma) in serum free DMEM for 30 min at 37 °C. DCFH-DA was de-esterified intracellularly and turned into highly fluorescent 2′-7′-dichlorofluorescein upon oxidation by cellular esterases. Levels of intracellular oxidative stress were reflected by DCF fluorescence intensity (excitation wavelength 485 nm, fluorescence wavelength 530 nm).
Cells were collected for detection of MDA, SOD and GSH activities using specific assay kits (NJJC Bio, Nanjing, China) according to the manufacturer’s instructions.
Terminal deoxynucleotidyl transferase-mediated 2’-deoxyuridine 5’-triphosphate nick-end labeling assay (TUNEL)
Kidney tissues embedded in Tissue-Tek Optimal Cutting Temperature (OCT) compound or cells planted in 96-well plates were prepared for TUNEL analysis using the in situ Cell Death Detection kit (Roche Applied Science) according to the manufacturer’s instructions. Cells with positive nuclear staining with DNA breakage were identified and counted by fluorescence microscopy. The apoptotic index was defined as ((number of apoptotic cells/total number of nucleated cells) ×100).
Mitochondrial membrane potential (∆Ψm) measurement
∆Ψm of NRK-52E cells was measured by a fluorescent, lipophilic and cationic probe, JC-1 (Beyotime), according to the manufacturer’s instructions. NRK-52E cells were planted in 96-well plates at a density of 5000 cells/well and the H/R protocol was performed as above. Then, the cells were incubated with JC-1 staining solution for 20 min at 37 °C. Fluorescence was detected with a Fluostar Optima microplate reader (BMG Technologies). The wavelengths of excitation and emission were 490 nm and 535 nm for detection of monomeric form of JC-1. 525 nm and 590 nm were used to detect aggregation of JC-1. The ratio of ‘red’ to ‘green’ fluorescence represented ∆Ψm of NRK-52E cells.
ER stress assessment
To assay ER stress, cells were cultured to 70% to 80% confluence and then pretreated with GLPP for 12 h. Subsequently, TM (2 μg/ml) or 4-PBA (5 mM) (Sigma) was incubated with the cells in DMEM containing 10% FBS for 24 h. After the completion of the experiments, the cells were collected for Western blot analysis.
Western blot analysis
Tissues or cells were homogenized in RIPA lysis buffer containing a protease inhibitor cocktail (Roche). Membrane protein, cytosolic protein and mitochondrial protein were isolated using the Membrane/Cytosol or Mitochondria/Cytosol Protein Fractionation Kit according to the manufacturer’s protocol (Beyotime Inst Biotech). Identical amounts of protein samples were separated by SDS-PAGE, blotted onto a PVDF membrane, and incubated with antibodies against p47phox (Bioworld), Mn-SOD (ABclonal), Bax, Bcl-2, caspase-12, CHOP, p-JNK, β-actin (Santa Cruz), p53, caspase-3, cleaved caspase-3, GRP78 (Cell Signaling Technology), JNK (ABclonal), p-p53, or cytochrome-c (Abcam) at 4 °C overnight. Then, goat anti-rabbit IgG or goat anti-mouse IgG (Santa Cruz) were added and the blots were developed with an ECL plus kit (Amersham Biosciences). The images were scanned with an Epson scanning system and the data were analyzed with Quantity-one software. The data are expressed as the values relative to the sham or control value.
All results are represented as the mean ± SEM. Data involving only two groups was analyzed using a two-tailed student t-test assuming unequal variances. When more than two experimental groups were compared, the data was analyzed using the Tukey-Kramer test with Prism 5.0 software to compare data between individual experimental groups. A p-value of <0.05 was considered to be statistically significant for all tests.
How to cite this article: Zhong, D. et al.Ganoderma lucidum polysaccharide peptide prevents renal ischemia reperfusion injury via counteracting oxidative stress. Sci. Rep.5, 16910; doi: 10.1038/srep16910 (2015).
Yang, G., Yang, L., Zhuang, Y., Qian, X. & Shen, Y. Ganoderma lucidum polysaccharide exerts anti-tumor activity via MAPK pathways in HL-60 acute leukemia cells. J Recept Signal Transduct Res. 20, 1–8 (2014).
Lin, Z. B. & Zhang, H. N. Anti-tumor and immunoregulatory activities of Ganoderma lucidum and its possible mechanisms. Acta pharmacol Sin. 25, 1387–1395 (2004).
Xu, Z., Chen, X., Zhong, Z., Chen, L. & Wang, Y. Ganoderma lucidum polysaccharides: immunomodulation and potential anti-tumor activities. Am J Chin Med. 39, 15–27 (2011).
Soares, A. A. et al. Hepatoprotective effects of mushrooms. Molecules. 18, 7609–7630 (2013).
Wasser, S. P. & Weis, A. L. Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: a modern perspective. Crit Rev Immunol. 19, 65–96 (1999).
Chang, C. J. et al. Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. Nat commun. 6, 7489 (2015).
Zhang, W. et al. Neuroprotective effect of pretreatment with ganoderma lucidum in cerebral ischemia/reperfusion injury in rat hippocampus. Neural Regen Res. 9, 1446–1452 (2014).
Cao, Q. Z. & Lin, Z. B. Antitumor and anti-angiogenic activity of Ganoderma lucidum polysaccharides peptide. Acta Pharmacol Sin. 25, 833–838 (2004).
Ho, Y. W. et al. Ganoderma lucidum polysaccharide peptide reduced the production of proinflammatory cytokines in activated rheumatoid synovial fibroblast. Mol Cell Biochem. 301, 173–179 (2007).
Cao, Q. Z. & Lin, Z. B. Ganoderma lucidum polysaccharides peptide inhibits the growth of vascular endothelial cell and the induction of VEGF in human lung cancer cell. Life Sci. 78, 1457–1463 (2006).
You, Y. H. & Lin, Z. B. Protective effects of Ganoderma lucidum polysaccharides peptide on injury of macrophages induced by reactive oxygen species. Acta Pharmacol Sin. 23, 787–791 (2002).
Xue, J. L. et al. Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol. 17, 1135–1142 (2006).
Lieberthal, W. & Levine, J. S. Mechanisms of apoptosis and its potential role in renal tubular epithelial cell injury. Am J Physiol. 271, F477–488 (1996).
Kloner, R. A., Przyklenk, K. & Whittaker, P. Deleterious effects of oxygen radicals in ischemia/reperfusion. Resolved and unresolved issues. Circulation. 80, 1115–1127 (1989).
Li, C. & Jackson, R. M. Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am J Physiol Cell Physiol. 282, C227–241 (2002).
Sharfuddin, A. A. & Molitoris, B. A. Pathophysiology of ischemic acute kidney injury. Nat Rev Nephrol. 7, 189–200 (2011).
Hoppins, S. & Nunnari, J. Cell Biology. Mitochondrial dynamics and apoptosis–the ER connection. Science. 337, 1052–1054 (2012).
Mahfoudh-Boussaid, A. et al. Attenuation of endoplasmic reticulum stress and mitochondrial injury in kidney with ischemic postconditioning application and trimetazidine treatment. J Biomed Sci. 19, 71 (2012).
Nielsen, F., Mikkelsen, B. B., Nielsen, J. B., Andersen, H. R. & Grandjean, P. Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors. Clin Chem. 43, 1209–1214 (1997).
Paller, M. S., Hoidal, J. R. & Ferris, T. F. Oxygen free radicals in ischemic acute renal failure in the rat. J Clin Invest. 74, 1156–1164 (1984).
Nakagawa, T., Yokozawa, T., Satoh, A. & Kim, H. Y. Attenuation of renal ischemia-reperfusion injury by proanthocyanidin-rich extract from grape seeds. J Nutr Sci Vitaminol (Tokyo). 51, 283–286 (2005).
Ozturk, H. et al. Protective effects of rosmarinic acid against renal ischaemia/reperfusion injury in rats. J Pak Med Assoc. 64, 260–265 (2014).
Yun, Y. et al. Ischemic postconditioning modified renal oxidative stress and lipid peroxidation caused by ischemic reperfusion injury in rats. Transplant Proc. 41, 3597–3602 (2009).
Circu, M. L. & Aw, T. Y. Reactive oxygen species, cellular redox systems and apoptosis. Free Radic Biol Med. 48, 749–762 (2010).
Youle, R. J. & Strasser, A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol. 9, 47–59 (2008).
Song, H. et al. The NADPH oxidase inhibitor DPI can abolish hypoxia-induced apoptosis of human kidney proximal tubular epithelial cells through Bcl2 up-regulation via ERK activation without ROS reduction. Life Sci. 126, 69–75 (2015).
Ola, M. S., Nawaz, M. & Ahsan, H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis. Mol Cell Biochem. 351, 41–58 (2011).
Kurokawa, M. & Kornbluth, S. Caspases and kinases in a death grip. Cell. 138, 838–854 (2009).
Sun, J., He, H. & Xie, B. J. Novel antioxidant peptides from fermented mushroom Ganoderma lucidum. J Agric Food Chem. 52, 6646–6652 (2004).
Ron, D. & Walter, P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol. 8, 519–529 (2007).
Rao, R. V. et al. Coupling endoplasmic reticulum stress to the cell death program: role of the ER chaperone GRP78. FEBS Lett. 514, 122–128 (2002).
Ohse, T. et al. Albumin induces endoplasmic reticulum stress and apoptosis in renal proximal tubular cells. Kidney Int. 70, 1447–1455 (2006).
Cao, Y. et al. Role of endoplasmic reticulum stress in apoptosis of differentiated mouse podocytes induced by high glucose. Int J Mol Med. 33, 809–816 (2014).
Gao, X. et al. The nephroprotective effect of tauroursodeoxycholic acid on ischaemia/reperfusion-induced acute kidney injury by inhibiting endoplasmic reticulum stress. Basic Clin Pharmacol Toxicol. 111, 14–23 (2012).
Hammadi, M. et al. Modulation of ER stress and apoptosis by endoplasmic reticulum calcium leak via translocon during unfolded protein response: involvement of GRP78. FASEB J. 27, 1600–1609 (2013).
Lee, A. S. The ER chaperone and signaling regulator GRP78/BiP as a monitor of endoplasmic reticulum stress. Methods. 35, 373–381 (2005).
Noh, M. R., Kim, J. I., Han, S. J., Lee, T. J. & Park, K. M. C/EBP homologous protein (CHOP) gene deficiency attenuates renal ischemia/reperfusion injury in mice. Biochim Biophys Acta. 1852, 1895–1901 (2015).
Carlisle, R. E. et al. 4-Phenylbutyrate inhibits tunicamycin-induced acute kidney injury via CHOP/GADD153 repression. PloS One. 9, e84663 (2014).
Nakagawa, T. et al. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature. 403, 98–103 (2000).
Nakagawa, T. & Yuan, J. Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis. J Cell Biol. 150, 887–894 (2000).
Shibata, M. et al. Activation of caspase-12 by endoplasmic reticulum stress induced by transient middle cerebral artery occlusion in mice. Neuroscience. 118, 491–499 (2003).
Lakshmanan, A. P. et al. Modulation of AT-1R/CHOP-JNK-Caspase12 pathway by olmesartan treatment attenuates ER stress-induced renal apoptosis in streptozotocin-induced diabetic mice. Eur J Pharm Sci. 44, 627–634 (2011).
Yu, G. et al. 14,15-epoxyeicosatrienoic Acid suppresses cigarette smoke extract-induced apoptosis in lung epithelial cells by inhibiting endoplasmic reticulum stress. Cell Physiol Biochem. 36, 474–486 (2015).
Krajarng, A. et al. Apoptosis induction associated with the ER stress response through up-regulation of JNK in HeLa cells by gambogic acid. BMC Complement Altern Med. 15, 26 (2015).
Ibrahim, S. H. & Gores, G. J. Who pulls the trigger: JNK activation in liver lipotoxicity? J Hepatol. 56, 17–19 (2012).
Tang, Z. et al. TRAM1 protect HepG2 cells from palmitate induced insulin resistance through ER stress-JNK pathway. Biochem Biophys Res Commun. 457, 578–584 (2015).
Ichijo, H. et al. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science. 275, 90–94 (1997).
Bhardwaj, N., Katyal, P. & Sharma, A. K. Suppression of inflammatory and allergic responses by pharmacologically potent fungus Ganoderma lucidum. Recent Pat Inflamm Allergy Drug Discov. 8, 104–117 (2014).
Ranganathan, P. V., Jayakumar, C., Mohamed, R., Dong, Z. & Ramesh, G. Netrin-1 regulates the inflammatory response of neutrophils and macrophages and suppresses ischemic acute kidney injury by inhibiting COX-2-mediated PGE2 production. Kidney Int. 83, 1087–1098 (2013).
Jung, M. et al. Infusion of IL-10-expressing cells protects against renal ischemia through induction of lipocalin-2. Kidney Int. 81, 969–982 (2012).
Rabb, H., O’Meara, Y. M., Maderna, P., Coleman, P. & Brady, H. R. Leukocytes, cell adhesion molecules and ischemic acute renal failure. Kidney Int. 51, 1463–1468 (1997).
Shieh, Y. H. et al. Evaluation of the hepatic and renal-protective effects of Ganoderma lucidum in mice. Am J Chin Med. 29, 501–507 (2001).
Lai, K. N., Chan, L. Y., Tang, S. C. & Leung, J. C. Ganoderma extract prevents albumin-induced oxidative damage and chemokines synthesis in cultured human proximal tubular epithelial cells. Nephrol Dial Transplan. 21, 1188–1197 (2006).
Yan, Y. M. et al. Lingzhiols, unprecedented rotary door-shaped meroterpenoids as potent and selective inhibitors of p-Smad3 from Ganoderma lucidum. Org Lett. 15, 5488–5491 (2013).
Pan, D. et al. A novel proteoglycan from Ganoderma lucidum fruiting bodies protects kidney function and ameliorates diabetic nephropathy via its antioxidant activity in C57BL/6 db/db mice. Food Chem Toxicol. 63, 111–118 (2014).
Brooks, C., Wei, Q., Cho, S. G. & Dong, Z. Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. J Clin Invest. 119, 1275–1285 (2009).
This work was supported by National Natural Science Foundation of China grants 81330074, 81261160507, 81170632, 81370783, the 111 Project and the International Science & Technology Cooperation Program of China 2012DFA11070.
The authors declare no competing financial interests.
About this article
Cite this article
Zhong, D., Wang, H., Liu, M. et al. Ganoderma lucidum polysaccharide peptide prevents renal ischemia reperfusion injury via counteracting oxidative stress. Sci Rep 5, 16910 (2015). https://doi.org/10.1038/srep16910
Acta Pharmacologica Sinica (2021)
Ganoderma lucidum aqueous extract prevents hypobaric hypoxia induced memory deficit by modulating neurotransmission, neuroplasticity and maintaining redox homeostasis
Scientific Reports (2020)
Herbal or traditional medicine consumption in a Thai worker population: pattern of use and therapeutic control in chronic diseases
BMC Complementary and Alternative Medicine (2019)
Applied Microbiology and Biotechnology (2019)
Scientific Reports (2017)